RTI uses cookies to offer you the best experience online. By and clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Accept
  • Home
  • Impact
  • Publications
  • Multiple Sclerosis Patients' Benefit-Risk Preferences: Serious Adverse Event Risk versus Treatment Efficacy

Multiple Sclerosis Patients' Benefit-Risk Preferences: Serious Adverse Event Risk versus Treatment Efficacy

Johnson, F., Van Houtven, G., Ozdemir, S., Hass, S., White, J., Francis, G., Miller, D., & Phillips, T. (2009). Multiple Sclerosis Patients' Benefit-Risk Preferences: Serious Adverse Event Risk versus Treatment Efficacy. Journal of Neurology, 256, 554 - 562.

Publications Info

To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.

Recent Publications

Article

Cannabis use in college
Article

Shared genetic risk between eating disorder- and substance-use-related phenotypes
Article

Pharmacogenetic studies of thiopurine methyltransferase genotype-phenotype concordance and effect of methotrexate on thiopurine metabolism
OCCASIONAL PAPER

Agreements between public health organizations and food and beverage companies